In October 2024, seven Biologics companies received seven FDA inspections in North Carolina, according to the U.S. Food and Drug Administration (FDA).
This represents 50% of all inspections conducted in the state in October 2024.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
FDA Inspections in North Carolina During October 2024
| Project Area | No Action Indicated | Voluntary Action Indicated | Official Action Indicated |
|---|---|---|---|
| Blood and Blood Products | 6 | — | — |
| Food Composition, Standards, Labeling and Econ | — | 2 | — |
| Foodborne Biological Hazards | 3 | 3 | — |
| Human Cellular, Tissue, and Gene Therapies | 1 | — | — |
